IR Releases

Sarantis Group shall be distributing a 0.06 € dividend

PRESS RELEASE Sarantis Group shall be distributing a 0.06 € dividend. Specifically, upon proposal by the Group’s Board of Directors in the General Meeting of the Company’s shareholders, Sarantis  Group shall distribute a 0.

1st TRIMESTER RESULTS FOR GR. SARANTIS SA

PRESS RELEASE Rise in earnings and turnover for Sarantis at closing of the 1st Trimester 2003. Specifically, within the 1st trimester of 2003, Sarantis Group, on consolidated basis, increased its sales volume by 16.

Financial Results Announcement - Fiscal Year 2002

PRESS RELEASE Increase in sales volume by 18% and pre-tax earnings by 10% is disclosed in the consolidated results of Sarantis Group in 2002.  Specifically, the net Group sales for 2002 amounted to Euro 219 million with respect to Euro 185 million in 2001, while the pre-tax earnings amounted to Euro 18.

Strategic merge of LOBELIN SA & PHARMACARE SA subsidiary companies

PRESS RELEASE LOBELIN SA first entered the market of the nutritional supplements and vitamins in Greece in 1981, after 21 years continues its successful, upward trend at the health & care products’ field after 21 years and it is merging with PHARMACARE SA, amplifying the existing product portfolio with well-known and successful Korff, ClearBlue, Manicare & Filovit brands.

9-MONTHS 2002 PERIOD RESULTS FOR SARANTIS GROUP

PRESS RELEASE Increase in results both in terms of sales volume and net pre-tax earnings is disclosed in the consolidated balance sheet of Sarantis Group. Specifically, the consolidated turnover of Sarantis reached a total of Euro 153.

BUY-OUT OF 45% OF PHARMACARE BY GR. SARANTIS SA

First Semester 2002 Financial Results of the Sarantis Group

PRESS RELEASE The consolidated results of the Sarantis Group for the first semester of 2002 feature a sales and EBITDA increase of 19% and 20%, respectively, as compared to the same period of the previous year.

GROUP SARANTIS FIRST QUARTER FINANCIAL RESULTS